Dr. Reddy’s launches Progesterone Capsules is US markets

22 Apr 2017 Evaluate

Dr. Reddy’s Laboratories has launched Progesterone Capsules, 100 mg and 200 mg, a therapeutic equivalent generic version of Prometrium (Progesterone) Capsules in the United States market, approved by the U.S. Food and Drug Administration (USFDA).

The company’s Progesterone Capsules, 100 mg and 200 mg, are available in bottle count size of 100. Prometrium is a registered trademark of ABBVIE Products LLC.

The Prometrium brand and generic had US sales of around $153 million MAT for the most recent twelve months ending in February 2017.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1248.00 -5.60 (-0.45%)
02-Jan-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.00
Dr. Reddys Lab 1248.00
Cipla 1503.80
Zydus Lifesciences 914.60
Lupin 2097.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×